Peripheral blood dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART

被引:49
作者
Otero, M
Nunnari, G
Leto, D
Sullivan, J
Wang, FX
Frank, I
Xu, Y
Patel, C
Dornadula, G
Kulkosky, J
Pomerantz, RJ
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll,Dorrance H Hamilton Labs, Dept Med,Ctr Human Virol & Biodef, Div Infect Dis & Environm Med, Philadelphia, PA 19107 USA
[2] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA
[3] Chestnut Hill Coll, Dept Biol, Philadelphia, PA 19118 USA
关键词
D O I
10.1089/088922203771881194
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells ( DCs) are potent antigen- presenting cells, and their physiological localization in tissues that interact with the external environment is important as a first barrier against pathogens such as human immunodeficiency virus type I ( HIV- 1). Several models have been proposed to explain the possible role of DCs as a reservoir for HIV- 1 in patients on virally suppressive highly active antiretroviral therapy ( HAART). However, the low yield of cell isolates has made this evaluation a difficult task. The present study analyzes whether peripheral blood DCs from HIV- 1- infected individuals on virally suppressive HAART, with plasma HIV- 1 RNA levels of less than 50 copies/ ml, carry either HIV- 1 provirus and/ or HIV- 1 virions. Peripheral blood DCs were isolated from a cohort of 10 HIV- 1- seropositive men taking suppressive HAART. In five patients, plasmacytoid and myeloid dendritic cells were isolated to attempt to identify their respective roles in HIV- 1 residual disease. Viral out- growth assays were performed in vitro, as well as gag and R/ U5 polymerase chain reaction ( PCR) amplification of viral RNA and DNA, respectively, from DC and peripheral blood mononuclear cell ( PBMC) extracts. Fluorescence activated cell- sorting ( FACS) data revealed cellular yields from 85.90 to 95.18%, of relatively pure DCs isolated from patients' PBMCs. Although HIV- 1 RNA gag and DNA RU/ 5 were detected in all PBMC samples isolated from the patients, proviral DNA and viral RNA forms were not detected in any of the DC isolates. In addition, no replication- competent virus was demonstrated in DC coculture assays, while virus was isolated from each patients' CD8(+) T- lymphocyte- depleted PBMC cocultures. Furthermore, HIV- 1 gag proviral DNA was not detected in either plasmacytoid or myeloid DC subfractions. The current study suggests that in HIV- 1- infected individuals treated with suppressive HAART, peripheral blood DCs do not carry HIV- 1 proviral DNA or viral particles attached to their surface. These populations of peripheral blood DCs are likely not a major HIV- 1 reservoir in patients on HAART with clinically undetectable plasma viral RNA.
引用
收藏
页码:1097 / 1103
页数:7
相关论文
共 32 条
[1]   DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS [J].
CAMERON, PU ;
FREUDENTHAL, PS ;
BARKER, JM ;
GEZELTER, S ;
INABA, K ;
STEINMAN, RM .
SCIENCE, 1992, 257 (5068) :383-386
[2]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[3]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[4]   Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1 [J].
Donaghy, H ;
Gazzard, B ;
Gotch, F ;
Patterson, S .
BLOOD, 2003, 101 (11) :4505-4511
[5]   Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].
Dornadula, G ;
Zhang, H ;
VanUitert, B ;
Stern, J ;
Livornese, L ;
Ingerman, MJ ;
Witek, J ;
Kedanis, RJ ;
Natkin, J ;
DeSimone, J ;
Pomerantz, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632
[6]   Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups [J].
Dornadula, G ;
Nunnari, G ;
Vanella, M ;
Roman, J ;
Babinchak, T ;
DeSimone, J ;
Stern, J ;
Braffman, M ;
Zhang, H ;
Pomerantz, RJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11) :1682-1687
[7]   Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].
Finzi, D ;
Hermankova, M ;
Pierson, T ;
Carruth, LM ;
Buck, C ;
Chaisson, RE ;
Quinn, TC ;
Chadwick, K ;
Margolick, J ;
Brookmeyer, R ;
Gallant, J ;
Markowitz, M ;
Ho, DD ;
Richman, DD ;
Siliciano, RF .
SCIENCE, 1997, 278 (5341) :1295-1300
[8]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[9]   Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover [J].
Gummuluru, S ;
KewalRamani, VN ;
Emerman, M .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10692-10701
[10]   High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors [J].
Gupta, P ;
Mellors, J ;
Kingsley, L ;
Riddler, S ;
Singh, MK ;
Schreiber, S ;
Cronin, M ;
Rinaldo, CR .
JOURNAL OF VIROLOGY, 1997, 71 (08) :6271-6275